ImmunovantIMVT
那斯達克 · USD
38.94
-0.63
(-1.59%)
盤中 09/09 11:37 (UTC+8)
09/09 11:37 (UTC+8)
ImmunovantIMVT
38.94
-0.63
(-1.59%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 160,323 | 159,554 | 114,362 | 131,762 | 127,224 | 113,825 | - | 115,743 | - | 80,879 |
研發費用 | 142,631 | 142,287 | 98,924 | 114,249 | 101,200 | 93,651 | 94,521 | 97,272 | 75,473 | 66,056 |
推銷及管理費用 | 17,692 | 17,267 | 15,438 | 17,513 | 26,024 | 20,174 | 19,782 | 18,471 | 18,808 | 14,823 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -160,323 | -159,554 | -114,362 | -131,762 | -127,224 | -113,825 | -114,303 | -115,743 | -94,281 | -80,879 |
其他收入及費用 | 7,099 | 8,854 | 5,279 | 5,854 | 7,524 | 7,959 | 3,333 | 6,703 | 7,208 | 5,792 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -153,224 | -150,700 | -109,083 | -125,908 | -119,700 | -105,866 | -110,970 | -109,040 | -87,073 | -75,087 |
所得稅 | - | -2,844 | 1,552 | 594 | 913 | 583 | 152 | 79 | 77 | 232 |
稅後純益 | -153,224 | -147,856 | -110,635 | -126,502 | -120,613 | -106,449 | -111,122 | -109,119 | -87,150 | -75,319 |
基本每股稅後盈餘(元) | -0.75 | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 | - |
稀釋每股稅後盈餘(元) | -0.75 | -0.73 | -0.61 | -0.72 | -0.71 | -0.63 | -0.76 | -0.74 | -0.60 | -0.52 |
基本平均股數(千股) | 205545.00 | 203709.00 | 181513.00 | 173643.00 | 170872.00 | 166732.00 | 146922.00 | 146468.00 | 146085.00 | - |
稀釋平均股數(千股) | 205545.00 | 203709.00 | 181513.00 | 173643.00 | 170872.00 | 166732.00 | 146922.00 | 146468.00 | 146085.00 | - |
還原基本每股稅後盈餘(元) | -0.75 | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 | - |
還原稀釋每股稅後盈餘(元) | -0.75 | -0.73 | -0.61 | -0.72 | -0.71 | -0.63 | -0.76 | -0.74 | -0.60 | -0.52 |
還原基本平均股數(千股) | 205,545 | 203,709 | 181,513 | 173,643 | 170,872 | 166,732 | 146,922 | 146,468 | 146,085 | - |
還原稀釋平均股數(千股) | 205,545 | 203,709 | 181,513 | 173,643 | 170,872 | 166,732 | 146,922 | 146,468 | 146,085 | - |
EBITDA(千元) | -153,132 | -150,604 | -108,982 | -125,803 | -119,593 | -105,757 | -110,871 | -108,951 | -86,993 | -75,023 |